ARD:被诊断患有炎症性关节炎的男性生育能力受损:一项大型多中心研究的结果 (iFAME-Fertility)

2021-12-28 MedSci原创 MedSci原创

在生育年龄高峰之前和期间被诊断为IA的男性生育率较低,无子女率较高,生育问题较多。迫切需要提高认识并进一步研究这种关联背后的原因。

     目的: 脊柱关节炎(SpA)类风湿性关节炎(RA)是可以在男性生育年龄高峰之前或期间影响他们的炎症性关节炎(IA)的常见原因。IA对男性生育能力的影响尚不清楚。而一些经常使用的抗风湿药与可逆或不可逆的睾丸毒性有关。该研究的目标是评估IA对几种男性生育结果的影响;生育率(每个人的亲生子女数)、计划生育、无子女和生育问题。

     方法:研究团队进行了一项多中心横断面研究 (iFAME-Fertility)。邀请40岁或40岁以上且表明其家庭规模完整的IA男性参与。参与者完成了一份问卷,其中包括人口统计学、医学和生育相关问题。为分析IA对生育率的影响,根据诊断时的年龄将患者分组:≤30岁(育龄高峰前)、31-40岁(高峰期)和≥ 41岁(高峰后)。

      结果:共有628名被诊断患有IA的参与者被纳入。诊断≤30岁的男性的平均子女数 (1.32 (SD 1.14)) 低于诊断为3140岁的男性 (1.60 (SD 1.35)) 和诊断≥41岁的男性 (1.88 (SD 1.14)),差异具有统计学显著性 (p=0.0004)。诊断为30岁以下和31-40岁的男性非自愿无子女的百分比(12.03% VS 10.34% VS3.98%p=0.001)以及报告接受过生育问题医学评估的男性百分比 (20.61 %20.69% 11.36%p=0.027)在统计学上显著高于诊断为41岁以上的男性。

     结论:这是第一项表明IA会损害男性生育能力的研究。在生育年龄高峰之前和期间被诊断为IA的男性生育率较低,无子女率较高,生育问题较多。迫切需要提高认识并进一步研究这种关联背后的原因。

出处:

Perez-Garcia LF, Röder E, Goekoop RJ, et al. Impaired fertility in men diagnosed with inflammatory arthritis: results of a large multicentre study (iFAME-Fertility). Annals of the Rheumatic Diseases 2021;80:1545-1552.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1909520, encodeId=c276190952092, content=<a href='/topic/show?id=16c6430324c' target=_blank style='color:#2F92EE;'>#多中心研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43032, encryptionId=16c6430324c, topicName=多中心研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Thu Sep 08 13:27:29 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904101, encodeId=a34c19041018e, content=<a href='/topic/show?id=7d454302945' target=_blank style='color:#2F92EE;'>#多中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43029, encryptionId=7d454302945, topicName=多中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Mar 08 09:27:29 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989679, encodeId=6c4219896e905, content=<a href='/topic/show?id=474ce2356c' target=_blank style='color:#2F92EE;'>#FAME#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7235, encryptionId=474ce2356c, topicName=FAME)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Mon Aug 22 15:27:29 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266376, encodeId=eb5312663e690, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Wed Dec 29 01:27:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515747, encodeId=0fc41515e47fc, content=<a href='/topic/show?id=c8e76e0205c' target=_blank style='color:#2F92EE;'>#炎症性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67020, encryptionId=c8e76e0205c, topicName=炎症性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af0610859509, createdName=ms1756883563247400, createdTime=Wed Dec 29 01:27:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547508, encodeId=2da8154e5080d, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Wed Dec 29 01:27:29 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1909520, encodeId=c276190952092, content=<a href='/topic/show?id=16c6430324c' target=_blank style='color:#2F92EE;'>#多中心研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43032, encryptionId=16c6430324c, topicName=多中心研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Thu Sep 08 13:27:29 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904101, encodeId=a34c19041018e, content=<a href='/topic/show?id=7d454302945' target=_blank style='color:#2F92EE;'>#多中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43029, encryptionId=7d454302945, topicName=多中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Mar 08 09:27:29 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989679, encodeId=6c4219896e905, content=<a href='/topic/show?id=474ce2356c' target=_blank style='color:#2F92EE;'>#FAME#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7235, encryptionId=474ce2356c, topicName=FAME)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Mon Aug 22 15:27:29 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266376, encodeId=eb5312663e690, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Wed Dec 29 01:27:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515747, encodeId=0fc41515e47fc, content=<a href='/topic/show?id=c8e76e0205c' target=_blank style='color:#2F92EE;'>#炎症性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67020, encryptionId=c8e76e0205c, topicName=炎症性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af0610859509, createdName=ms1756883563247400, createdTime=Wed Dec 29 01:27:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547508, encodeId=2da8154e5080d, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Wed Dec 29 01:27:29 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1909520, encodeId=c276190952092, content=<a href='/topic/show?id=16c6430324c' target=_blank style='color:#2F92EE;'>#多中心研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43032, encryptionId=16c6430324c, topicName=多中心研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Thu Sep 08 13:27:29 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904101, encodeId=a34c19041018e, content=<a href='/topic/show?id=7d454302945' target=_blank style='color:#2F92EE;'>#多中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43029, encryptionId=7d454302945, topicName=多中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Mar 08 09:27:29 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989679, encodeId=6c4219896e905, content=<a href='/topic/show?id=474ce2356c' target=_blank style='color:#2F92EE;'>#FAME#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7235, encryptionId=474ce2356c, topicName=FAME)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Mon Aug 22 15:27:29 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266376, encodeId=eb5312663e690, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Wed Dec 29 01:27:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515747, encodeId=0fc41515e47fc, content=<a href='/topic/show?id=c8e76e0205c' target=_blank style='color:#2F92EE;'>#炎症性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67020, encryptionId=c8e76e0205c, topicName=炎症性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af0610859509, createdName=ms1756883563247400, createdTime=Wed Dec 29 01:27:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547508, encodeId=2da8154e5080d, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Wed Dec 29 01:27:29 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-08-22 chenshujs
  4. [GetPortalCommentsPageByObjectIdResponse(id=1909520, encodeId=c276190952092, content=<a href='/topic/show?id=16c6430324c' target=_blank style='color:#2F92EE;'>#多中心研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43032, encryptionId=16c6430324c, topicName=多中心研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Thu Sep 08 13:27:29 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904101, encodeId=a34c19041018e, content=<a href='/topic/show?id=7d454302945' target=_blank style='color:#2F92EE;'>#多中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43029, encryptionId=7d454302945, topicName=多中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Mar 08 09:27:29 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989679, encodeId=6c4219896e905, content=<a href='/topic/show?id=474ce2356c' target=_blank style='color:#2F92EE;'>#FAME#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7235, encryptionId=474ce2356c, topicName=FAME)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Mon Aug 22 15:27:29 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266376, encodeId=eb5312663e690, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Wed Dec 29 01:27:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515747, encodeId=0fc41515e47fc, content=<a href='/topic/show?id=c8e76e0205c' target=_blank style='color:#2F92EE;'>#炎症性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67020, encryptionId=c8e76e0205c, topicName=炎症性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af0610859509, createdName=ms1756883563247400, createdTime=Wed Dec 29 01:27:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547508, encodeId=2da8154e5080d, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Wed Dec 29 01:27:29 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-12-29 lmm397
  5. [GetPortalCommentsPageByObjectIdResponse(id=1909520, encodeId=c276190952092, content=<a href='/topic/show?id=16c6430324c' target=_blank style='color:#2F92EE;'>#多中心研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43032, encryptionId=16c6430324c, topicName=多中心研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Thu Sep 08 13:27:29 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904101, encodeId=a34c19041018e, content=<a href='/topic/show?id=7d454302945' target=_blank style='color:#2F92EE;'>#多中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43029, encryptionId=7d454302945, topicName=多中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Mar 08 09:27:29 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989679, encodeId=6c4219896e905, content=<a href='/topic/show?id=474ce2356c' target=_blank style='color:#2F92EE;'>#FAME#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7235, encryptionId=474ce2356c, topicName=FAME)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Mon Aug 22 15:27:29 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266376, encodeId=eb5312663e690, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Wed Dec 29 01:27:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515747, encodeId=0fc41515e47fc, content=<a href='/topic/show?id=c8e76e0205c' target=_blank style='color:#2F92EE;'>#炎症性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67020, encryptionId=c8e76e0205c, topicName=炎症性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af0610859509, createdName=ms1756883563247400, createdTime=Wed Dec 29 01:27:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547508, encodeId=2da8154e5080d, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Wed Dec 29 01:27:29 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1909520, encodeId=c276190952092, content=<a href='/topic/show?id=16c6430324c' target=_blank style='color:#2F92EE;'>#多中心研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43032, encryptionId=16c6430324c, topicName=多中心研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Thu Sep 08 13:27:29 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904101, encodeId=a34c19041018e, content=<a href='/topic/show?id=7d454302945' target=_blank style='color:#2F92EE;'>#多中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43029, encryptionId=7d454302945, topicName=多中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Mar 08 09:27:29 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989679, encodeId=6c4219896e905, content=<a href='/topic/show?id=474ce2356c' target=_blank style='color:#2F92EE;'>#FAME#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7235, encryptionId=474ce2356c, topicName=FAME)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Mon Aug 22 15:27:29 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266376, encodeId=eb5312663e690, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Wed Dec 29 01:27:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515747, encodeId=0fc41515e47fc, content=<a href='/topic/show?id=c8e76e0205c' target=_blank style='color:#2F92EE;'>#炎症性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67020, encryptionId=c8e76e0205c, topicName=炎症性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af0610859509, createdName=ms1756883563247400, createdTime=Wed Dec 29 01:27:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547508, encodeId=2da8154e5080d, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Wed Dec 29 01:27:29 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

相关资讯

ACR 2021:类风湿性关节炎患者“撞见” ANCA 阳性和血管炎会怎样?

类风湿性关节炎合并ANCA阳性会怎样?合并血管炎又会怎样?哪种会被最先诊断出来?背后的免疫机制又是怎样呢?

J Periodontal Res:抗风湿药对类风湿性关节炎和牙周炎患者牙周状况的影响

近年来,类风湿性关节炎(RA)与牙周炎的相关性已成为研究热点,但目前尚无针对RA和牙周炎患者的用药建议。近日,发表于J Periodontal Res的一项系统综述评价了各种抗风湿药物对牙周状况的影响

A&R: IL-34重编程糖酵解和破骨性类风湿性关节炎巨噬细胞

IL-34是一种新型内源性因子,可重塑高代谢M34巨噬细胞并促进其与T效应细胞的交叉调节从而引起RA的炎症性骨破坏。

A&R:早期类风湿性关节炎患者和类风湿性关节炎高风险个体与健康人群相比的口腔微生物组差异

本研究的目的是评估早期RA患者和有患RA风险个体与健康对照组相比的口腔微生物组和牙周状况。

这些治疗类风湿关节炎的药物可增加带状疱疹发生风险

带状疱疹(HZ)是类风湿关节炎(RA)患者常见的合并症之一,其发生率高于一般健康人群,大大增加了RA患者的疾病痛苦和医疗负担。哪些药物会增加RA患者HZ的风险呢?